Sintilimab Injection with 5-fu-based low dose chemotherapy and antiangiogenic first-line standard therapy for gastric and gastroesophageal junction adenocarcinoma after failure
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Sintilimab (Primary) ; Bevacizumab; Fluorouracil; Oxaliplatin; Paclitaxel
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 04 Aug 2020 New trial record